Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
Newcells’ technical experts precisely outlined the problem and the questions to be answered during an in-depth discussion with the client. The client wanted to quickly determine whether their AAV ...
- Initiated ARTEMIS, the first-ever registrational intravitreal gene therapy trial, in both treatment-experienced and treatment-naive patients with wet AMD - Presented the first human data mapping ...
News-Medical.Net on MSN
TRPM1 loss drives rhythmic activity across retinal diseases
Rhythmic electrical activity in the retina (known as pathological oscillations) has been observed in several eye diseases, including congenital stationary night blindness (CSNB) and retinitis ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics, Inc., a techbio company pioneering applications of artificial intelligence to engineering AAV capsids that expand the potential of genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback